Dynamic Technology Lab Private LTD Arcutis Biotherapeutics, Inc. Transaction History
Dynamic Technology Lab Private LTD
- $601 Million
- Q4 2024
A detailed history of Dynamic Technology Lab Private LTD transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Dynamic Technology Lab Private LTD holds 17,603 shares of ARQT stock, worth $301,187. This represents 0.04% of its overall portfolio holdings.
Number of Shares
17,603Holding current value
$301,187% of portfolio
0.04%Shares
2 transactions
Others Institutions Holding ARQT
# of Institutions
218Shares Held
129MCall Options Held
2.02MPut Options Held
202K-
Jennison Associates LLC12.3MShares$211 Million0.11% of portfolio
-
Suvretta Capital Management, LLC New York, NY11.4MShares$195 Million6.61% of portfolio
-
Rubric Capital Management LP New York, NY11MShares$188 Million2.52% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA8.79MShares$150 Million7.34% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$148 Million0.0% of portfolio
About Arcutis Biotherapeutics, Inc.
- Ticker ARQT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,187,500
- Market Cap $1.03B
- Description
- Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...